Early age at first intercourse, increased number of sexual partners, lack of circumcision and history of sexually transmitted diseases (STDs) are associated with prostate cancer. There has been no investigation of the effect of these factors on prostate health at an early age. Previously collected serum samples from STD clinic attendees were tested retrospectively for anti-chlamydial antibodies, and prostate specific antigen (PSA) concentration. Patients at an STD clinic were interviewed regarding age of first intercourse, number of sexual partners and circumcision status. This was compared to clinical diagnosis, anti-chlamydial antibody titre and PSA concentration. The results showed: (1) that of patients with an anti-chlamydial antibody titre equal or greater than 1 in 64 (n ¼ 27) 37% had a PSA concentration greater than 0.8 ng/ml while those with a titre less than 1/64 (n ¼ 201) only 17% had a PSA > 0.8 (P < 0.05). (2) No association was found with circumcision status. (3) Early age of first intercourse and more than 20 sexual partners were associated with a synergistic increase in mean anti-chlamydial antibody titre and a mean PSA concentration of 1.2 ng/ml (95% CI 0.56 -1.76). It is concluded that these results provide the first evidence that sexual behaviour related risk factors for prostate cancer do damage the prostate at an early age. Though they do not prove that infection is a cause of prostate cancer they do justify further research into the specificity of agents involved and impact of antibiotic treatment. Prostate Cancer and Prostatic Diseases (2001) 4, 228-231.
Introduction
There is increasing evidence that low grade infection plays a role in the development of several cancers. Chronic osteomyelitis and osteogenic sarcoma, 1 persistent gastric infection with Helicobacter pylori and stomach cancer 2 and cervical cancer and human papillomavirus (HPV) infection 3 are examples of this process. Less well established is evidence for an association between prostate cancer and persistent sexually transmitted infection.
The relative risk of prostate cancer is increased with sexual behaviours such as early age of first intercourse, large number of sexual partners and history of any sexually acquired infection. 4 It has been suggested 5 that subclinical prostate damage from such persistent infection promotes progression from latent foci of adenocarcinoma within the prostate, which are found at an equal incidence worldwide to invasive disease, 6 which has a geographic epidemiology similar to that of cervical cancer and heterosexual AIDS.
As there have been no reports on whether these sexual risk factors for prostate cancer have an effect on the prostate early in life, this study set out to assess the impact of Chlamydia infection, early age of first intercourse, number of sexual partners and circumcision on prostate specific antigen (PSA) levels as a marker for prostate damage in a group of patients attending a sexually transmitted disease (STD) clinic.
Methods
The population sampled were men attending an STD clinic covering two goldmines in Carltonville, South Africa. The first phase of this study retrospectively studied serum samples that had been collected as part of ongoing HIV epidemiological research at the South African Institute for Medical Research (SAIMR). These had previously been tested for HIV, rapid plasma reagin (RPR) test for syphilis antibodies and micro-immunofluorescence for three anti-chlamydial antibodies. The samples were selected in sequence order, stratified to produce equal numbers of chlamydia positive and negative samples. These samples were tested for PSA concentration by laser nephalometry (Behring diagnostics).
The second stage of the study investigated sexual behaviour in all new patients attending the same STD clinic during the study period. They were interviewed using a questionnaire regarding sexual behaviour -age at first intercourse, number of sexual partners, and past history of STDs. A serum sample was taken from each patient and tested in the same way as the first group for anti-chlamydial antibodies, HIV and RPR, and serum PSA concentration.
Results
Two hundred and twenty-nine serum samples were tested. The mean serum PSA concentration was 0.64 ng/ ml, 95% confidence interval (95% CI) 0.53 -0.78. The PSA concentrations showed a bi-modal distribution ( Figure 1 ) suggesting that there may be a pathological process involved in raising PSA concentration in patients with levels > 0.8 ng/ml.
Anti-chlamydial antibody titre and PSA concentration
Three anti-chlamydial antibodies were tested for; the results are given as the geometric mean, ranging from 1 in 8 to 1 in 1024.
Antibody results were divided into three groups, negative: geometric mean titre 0, low titre: geometric mean titre < 1 in 64 and high titre: geometric mean titre 1 in 64. Table 1 shows that there is no significant difference between the mean PSA concentrations for each group. However among the high titre samples, there is a smaller proportion of PSA concentrations 0.4 than the negative and low titre groups, and a larger proportion of PSA concentrations greater than 0.8 ng/ml, ie 10/27 (37%) vs 34/201 (17%) (w 2 ¼ 4.96 P ¼ 0.05). Of the eight samples with a PSA recorded as less than 0.1, only one had detectable anti-chlamydial antibodies, and that was at the lowest titre.
Interviewed patients
All 83 new patients agreed to be interviewed. The mean age was 32 (range 18 -50 y). There was no significant difference in anti-chlamydial antibody titres and PSA concentrations between this sample and the previously collected samples. PSA concentration and anti-chlamydial antibody titre increased with age but this was not significant at the 5% level.
Circumcision status and PSA concentration
The majority of patients were uncircumcised and only 13 (16%) had been circumcised prior to first intercourse. Although this group had marginally lower PSA levels than the other groups (Table 2) the difference was not statistically significant.
PSA concentration and sexual practice
The mean age of first intercourse of the patients interviewed was 17 y (range 10 -25 y) Figure 2 shows a trend of increasing mean PSA concentration with decreasing age of first intercourse. The correlation coefficient is 7 0.75. There was a suggestion that men with 20 or more sexual partners during their lifetime (n ¼ 24) had a higher mean PSA concentration (0.78) than men with less than 20 partners (n ¼ 59, mean PSA ¼ 0.48) though this difference is not significant at the 5% level. There was however a suggestion of a synergistic effect between early age of first intercourse and the number of sexual partners on PSA levels, as only in men having first intercourse under the age of 16 was there an increased PSA level with increasing number of sexual partners and increased mean anti-chlamydial titre (Table 3) .
Discussion
There are no major studies of serum PSA in the 'normal' South African population, though in one study of 32 rural Africans with a mean age of 62 (range 52 -76) 74% had a PSA < 0.5 ng/ml. 7 The mean serum concentration among 'normal' American men, was 0.47 ng/ml (95% CI 0.28 -0.65) and 100% of men under 40 y had a PSA concentration less than 4.0 ng/ml. 8 Our mean age was 32 and mean PSA concentration was 0.64 ng/ml (95% CI 0.53 -0.78) and three men under 40 y had PSA concentrations greater than 4.0 ng/ml. This non-significant difference would suggest that our results are different from a normal population and may be a reflection of STD damage to the prostate. In one study acute asymptomatic prostatitis caused elevation of PSA greater than 4 ng/ml in 71% of patients, and chronic bacterial prostatitis was associated with elevation greater than 4 ng/ml in 15% of patients 9 Using the microimmunofluorescence test for anti-chlamydial antibodies patients with lymphogranuloma venereum (LGV) the sensitivity of the antibody assay was 100%, with a geometric mean titre of 1 in 512. This assay is less specific among men with symptoms of nonspecific urithritis (NSU) in a British population. Using a geometric mean titre of greater than 1 in 8 only has a sensitivity of 51% and specificity of 67%. If applied to our study, this means that among our negative serum samples, 49% would have had acute chlamydia infection. Clearly future studies need to use the specific chlamydial antigen tests though these have the disadvantage of being more invasive.
Despite the limitations of the antibody techniques our results suggest a significant increase in the proportion of high PSA concentrations among the high anti-chlamydial titre group. There is increasing evidence to support the need for further investigation in patients with acute and persistent chlamydial infections to clarify the relative difference of the effect of the prostate on these two extremes of chlamydial infection. 10 Although most epidemiogical investigations into prostate cancer confirms an association between occurrence of prostate cancer and age of first intercourse and number of sexual partners, 4 the data presented in this paper is the first piece of evidence to suggest that these risk factors do have a damaging effect on the prostate at an early age. Previously there has been argument as to whether these risk factors are associated with hormonal differences leading to prostate cancer or due to the infection itself. Our results provides supportive evidence to suggest that an infectious agent may be involved and that the prostate may be more susceptible to infection at a younger age.
As yet the universality of these results cannot be assumed as the sample was selected from a population of goldminers near Johannesburg. The act of gold mining itself may have an influence on the PSA, for example physical activity influences PSA levels. 11 Furthermore variations in testosterone level could also effect the result. A control group of goldmine workers never having attended the STD clinic would be required, or a matched group at an STD clinic in another country. As the sample studied was not large, population based studies will be important to indicate if these finding are maintained. If STD infection at an early age has an effect on prostate cancer incidence, it is important to know if early treatment or use of condoms reduces the later risk. There are ongoing studies in areas of Africa involving increased surveillance and treatment of STDs in an attempt to reduce HIV infection. 12 A study of PSA levels in these populations would be particularly interesting.
It is concluded that this study has provided suggestive evidence that STDs such as chlamydia could be a factor involved in the association between onset of sexual activity and the subsequent development of prostate cancer. However they do not prove that infection causes prostate cancer but justify further confirmation of these observations in larger populations and a study of patients entering treatment studies will be needed to clarify the significance of these preliminary observations.
